Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Arch Environ Contam Toxicol ; 69(4): 431-9, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26276034

RESUMEN

The objective of this work was to evaluate antioxidant defence and oxidative damage in organs (liver, gills, kidney, and brain) of five fish species (Aspius aspius, Esox lucius, Sander lucioperca, Abramis brama, Rutilus rutilus) from the long-term mercury-contaminated Skalka Reservoir in the Czech Republic. Special emphasis was placed on a comprehensive assessment of the factors that may affect the antioxidant response to mercury in fish. Antioxidant enzymes (glutathione reductase, glutathione peroxidase, and glutathione-S-transferase) did not significantly respond to mercury contamination. Levels of the analysed enzymes and oxidative damage to lipids were predominantly determined by a separate organ factor or species factor, or by the combination of both (p < 0.001). Levels of total glutathione and the reduced/oxidized glutathione ratio were influenced by mercury contamination in combination with their specific organ distribution (p < 0.001). Our results suggest that species and type of organ alone or in combination are more important factors than chronic exposure to mercury contamination with respect to effects on antioxidant defence in fish under field conditions. Our findings suggest that the main antioxidant defensive mechanism in fish from the studied long-term mercury contaminated site was the inter-tissue distribution of glutathione.


Asunto(s)
Mercurio/toxicidad , Percas/fisiología , Contaminantes Químicos del Agua/toxicidad , Animales , República Checa , Monitoreo del Ambiente , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Mercurio/análisis , Contaminantes Químicos del Agua/análisis
2.
Klin Onkol ; 28(4): 245-50, 2015.
Artículo en Checo | MEDLINE | ID: mdl-26299737

RESUMEN

BACKGROUNDS: Despite the fast development of new effective cytostatics and targeted therapy, the treatment efficiency of lung cancer is still insufficient. The systemic administration of drugs results in a decrease in drug concentrations in tumor site, particularly due to specific extracellular environment in lungs. Nanotransporters could serve as a platform, protecting a drug against these undesired effects, which may enhance its therapeutic index and reduce side effects of a drug. Moreover, nanotechnologies possess the potential to improve the diagnostics of lung cancer, and thus increase a survival rate of oncologic patients. AIM: The presented study is aimed to demonstrate the possibilities provided by nanotechnologies in the field of treatment and diagnostic of lung cancers and discuss the obstacles, which complicate a translation into clinical practice.


Asunto(s)
Neoplasias Pulmonares/tratamiento farmacológico , Nanomedicina , Humanos , Neoplasias Pulmonares/diagnóstico , Terapia Molecular Dirigida
3.
Bratisl Lek Listy ; 112(8): 435-40, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21863613

RESUMEN

This review gives a brief summary on clinical applications of MMPs and their determination. Primarily, the activity of MMPs in cancer formation, development and metastasis is discussed. Further, survey on methods including fluorimetric methods, zymographies, Western-blotting, immunocapture assay, enzyme-linked immunosorbent assay, immunocytochemistry and immunohistochemistry, phage display, multiple-enzyme/multiple-reagent system, activity profiling, chronopotentiometric stripping analysis and imaging methods for detection and determination of MMPs follows (Fig. 3, Ref. 100).


Asunto(s)
Metaloproteinasas de la Matriz/fisiología , Biomarcadores/análisis , Humanos , Metaloproteinasas de la Matriz/análisis , Metaloproteinasas de la Matriz/química , Neoplasias/diagnóstico , Neoplasias/fisiopatología
4.
Curr Med Chem ; 17(31): 3751-68, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20846107

RESUMEN

Matrix metalloproteinases (MMPs), also known as matrixins, belong to a group of zinc-dependent proteins, which are thought to play a central role in the breakdown of extracellular matrix. Collagen, elastin, gelatin and casein are major components cleaved by MMPs. The breakdown of these components is essential for many physiological processes such as embryonic development, morphogenesis, reproduction, and tissue resorption and remodelling. MMPs also participate in pathological processes such as arthritis, cancer, cardiovascular and neurological diseases. This review summarizes current knowledge regarding these proteins, their participation in physiological and pathophysiological roles, their involvement in activation and inhibition, and their interactions with other metal-binding proteins including metallothioneins.


Asunto(s)
Enfermedades Cardiovasculares/enzimología , Matriz Extracelular/metabolismo , Metaloproteinasas de la Matriz/metabolismo , Neoplasias/enzimología , Enfermedades Cardiovasculares/tratamiento farmacológico , Enfermedades Cardiovasculares/fisiopatología , Cisteína/metabolismo , Regulación Enzimológica de la Expresión Génica , Humanos , Inhibidores de la Metaloproteinasa de la Matriz , Metaloproteinasas de la Matriz/química , Metaloproteinasas de la Matriz/genética , Neoplasias/tratamiento farmacológico , Neoplasias/fisiopatología , Especificidad por Sustrato , Inhibidores Tisulares de Metaloproteinasas/metabolismo , Compuestos de Zinc/química , Compuestos de Zinc/metabolismo , Compuestos de Zinc/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA